Antibiotic and Antiseptic Susceptibility Profiles of Clinical <i>Pseudomonas aeruginosa</i> Isolates from Burn Wound Infections
DOI:
https://doi.org/10.3329/jsr.v18i2.84141Abstract
Pseudomonas aeruginosa is a major cause of burn wound infections, often exhibiting multidrug resistance. This study evaluated the antibiotic and antiseptic susceptibility patterns of P. aeruginosa isolated from burn patients. Burn wound swabs (n = 30) were collected prospectively and cultured on cetrimide agar. Isolates were identified by cultural, morphological, and biochemical tests. Antibiotic susceptibility was determined using the Kirby-Bauer disc diffusion method against 16 antibiotics, while antiseptic susceptibility was assessed by agar cup method against Hexisol, 70 % ethanol, Dettol, and Savlon. Out of 30 samples, 12 were culture positive and 6 yielded P. aeruginosa. All isolates were susceptible to colistin; however, the majority of tested antibiotics - including streptomycin, ciprofloxacin, nalidixic acid, cephalosporins, cotrimoxazole, amoxiclav, and nitrofurantoin - showed limited or no effectiveness. The multiple antibiotic resistance (MAR) index ranged between 0.75 and 1.00, reflecting high selective pressure from antibiotic exposure. Among the antiseptics tested, Hexisol demonstrated the strongest bactericidal activity, whereas 70% ethanol, Dettol, and Savlon exhibited comparatively lower efficacy. These results indicate that P. aeruginosa isolates from burn wounds display extensive drug resistance, along with reduced susceptibility to commonly used antiseptics. Enhanced infection control measures and judicious antibiotic use are crucial to limit the dissemination of these resistant pathogens in healthcare facilities.
Downloads
20
25
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
© Journal of Scientific Research
Articles published in the "Journal of Scientific Research" are Open Access articles under a Creative Commons Attribution-ShareAlike 4.0 International license (CC BY-SA 4.0). This license permits use, distribution and reproduction in any medium, provided the original work is properly cited and initial publication in this journal. In addition to that, users must provide a link to the license, indicate if changes are made and distribute using the same license as original if the original content has been remixed, transformed or built upon.
